Logo

Toronto Microarray Facility to Use Inforsense Analysis Software

Jul 13, 2004

NEW YORK, July 13 (GenomeWeb News) - InforSense said today that it has signed a software licensing agreement with the Center for Applied Genomics Microarray Facility at the Hospital for Sick Children in Toronto, Canada.

 

The facility has purchased a multi-user, multi-year license for the company's Knowledge Discovery Environment informatics system to analyze data from the Affymetrix GeneChip platform, Inforsense said.

 

Financial terms of the agreement were not provided.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.